BioCentury | Jul 20, 2018
Financial News

Neuraly raises $36M series A to develop microglia-targeted PD candidate

Neurodegeneration company Neuraly Inc. (Germantown, Md.) launched July 18 with a tranched $36 million series A round led by new investor D&D Pharmatech (Gyeonggi-do, Korea). Korean venture funds Smilegate, InterVest, LB Investment, Magna Investment, Geon...
BioCentury | Jul 18, 2018
Financial News

Neuraly debuts with $36M to target neurodegenerative diseases

Neurodegeneration company Neuraly Inc. (Germantown, Md.) launched Wednesday with a tranched $36 million series A round led by new investor D&D Pharmatech (Gyeonggi-do, Korea). Korean venture funds Smilegate, InterVest, LB Investment, Magna Investment, Geon Investment...
BioCentury | Jul 13, 2018
Finance

Pause for politics

...3/9/18 $60.0 $172.1 $171.2 -1% Acacia Pharma Group Ltd. (Euronext:ACPH) 3/2/18 $49.1 $233.9 $201.3 -14% DongKoo Bio & Pharma Co. Ltd....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...Biosciences LLC 12/29/17 Up to $100M Ph I/II Menlo Therapeutics Inc. 12/28/17 $85M Ph II DongKoo Bio & Pharma Co. Ltd....
Items per page:
1 - 4 of 4
BioCentury | Jul 20, 2018
Financial News

Neuraly raises $36M series A to develop microglia-targeted PD candidate

Neurodegeneration company Neuraly Inc. (Germantown, Md.) launched July 18 with a tranched $36 million series A round led by new investor D&D Pharmatech (Gyeonggi-do, Korea). Korean venture funds Smilegate, InterVest, LB Investment, Magna Investment, Geon...
BioCentury | Jul 18, 2018
Financial News

Neuraly debuts with $36M to target neurodegenerative diseases

Neurodegeneration company Neuraly Inc. (Germantown, Md.) launched Wednesday with a tranched $36 million series A round led by new investor D&D Pharmatech (Gyeonggi-do, Korea). Korean venture funds Smilegate, InterVest, LB Investment, Magna Investment, Geon Investment...
BioCentury | Jul 13, 2018
Finance

Pause for politics

...3/9/18 $60.0 $172.1 $171.2 -1% Acacia Pharma Group Ltd. (Euronext:ACPH) 3/2/18 $49.1 $233.9 $201.3 -14% DongKoo Bio & Pharma Co. Ltd....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...Biosciences LLC 12/29/17 Up to $100M Ph I/II Menlo Therapeutics Inc. 12/28/17 $85M Ph II DongKoo Bio & Pharma Co. Ltd....
Items per page:
1 - 4 of 4